Ing Groep Nv Organon & Co. Transaction History

Ing Groep Nv

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$10.95 - $17.32 $1.05 Million - $1.67 Million	-96,184 Reduced 75.04%	32,000 $461,000
Q3 2023 Oct 27, 2023	BUY	$16.59 - $23.77 $1.52 Million - $2.18 Million	91,749 Added 251.82%	128,184 $2.23 Million
Q2 2023 Aug 07, 2023	BUY	$19.27 - $24.63 $564,822 - $721,929	29,311 Added 411.44%	36,435 $758,000
Q1 2023 May 09, 2023	BUY	$21.42 - $32.08 $152,596 - $228,537	7,124 New	7,124 $167,000
Q2 2022 Aug 08, 2022	BUY	$31.66 - $38.9 $238,368 - $292,878	7,529 New	7,529 $254,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $1.01 Million - $1.3 Million	-33,093 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $338,564 - $438,468	11,809 Added 55.48%	33,093 $1.01 Million
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $14,372 - $17,891	502 Added 2.42%	21,284 $698,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $591,247 - $789,716	20,782 New	20,782 $629,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.